跳至主要内容
临床试验/NCT05089747
NCT05089747招募中不适用

MAster Protocol Studying the Impact of Blood Biopsy on Screening, Diagnosis, Diagnostic and Follow-up of Solid Cancer in Adult

Hospices Civils de Lyon12 个研究点 分布在 1 个国家目标入组 6,000 人开始时间: 2022年12月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
6,000
试验地点
12
主要终点
Liquid biopsy analyses

研究概览

简要总结

This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (>18y)
  • Owing a social security insurance
  • Any solid cancer diagnosed by histopathology or cytology
  • Patient with blood sampling required as per standard of care
  • Informed consent signed

排除标准

  • Refusal to participate
  • No blood sampling required as per standard of care
  • Hemoglobin < 7g/dl (< 9g/dl if respiratory or cardiovascular disease history)
  • Heterologous blood transfusion in the last 48 hours
  • Weight under 20 kg

结局指标

主要结局

Liquid biopsy analyses

时间窗: Day 0

Extraction of circulating DNA or circulating RNA followed by a tumoral cells extraction.

Standard technics of disease assessment

时间窗: Week 16

Genetic and transcriptomic explorations with immunofluorescence technique. Marking with specific markers of the tumor pathology. And enumaration of tumoral cells.

Correlation between outcome 1 and outcome 2

时间窗: year 5

Building a biological collection of blood samples and following, diagnosis and prediction of adult solid cancer.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验